| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |